Presentation TCT 2014 A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial Presenter: Bruno Scheller September 16, 2014
Presentation TCT 2014 A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___ Presenter: Guy F Prado Jr September 16, 2014
Presentation TCT 2014 2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___ Presenter: Clemens von Birgelen September 16, 2014
Presentation TCT 2014 Novel Patient-based Finite Element Simulation Framework To Evaluate Fatigue Resistance Of Coronary Stent Design Presenter: Peter Mortier September 16, 2014
Presentation TCT 2014 Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___ Presenter: James Min September 16, 2014
Presentation TCT 2014 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_ Presenter: Bernard De Bruyne September 16, 2014
Presentation TCT 2014 Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies? Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati September 15, 2014
Presentation TCT 2014 FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul September 15, 2014
Presentation TCT 2014 BioFreedom: From Pilot Results to the Leaders-Free Trial Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban September 15, 2014
Presentation TCT 2014 Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca September 15, 2014
Presentation TCT 2014 The Drug-Filled Stent: From Concept to Clinical Development Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman September 15, 2014
Presentation TCT 2014 TCT 599: Final Procedural, 30-Day and 6-Month Angiographic, Clinical, and OCT Outcomes from the DIRECT II Trial Using the Svelte Integrated Delivery System with Enzymatic Bioabsobable Sirolimus Coating Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Stefan Verheye September 15, 2014
Presentation TCT 2014 Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Michael Haude September 15, 2014
Presentation TCT 2014 The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Sameer I. Dani September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, John A. Ormiston September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker September 15, 2014